Therapy of necrobiotic xanthogranuloma - case series and review of the literature
Standard
Therapy of necrobiotic xanthogranuloma - case series and review of the literature. / Hansen, Inga; Ghandili, Susanne; Abeck, Finn; Booken, Nina; Schneider, Stefan W.
in: J DTSCH DERMATOL GES, Jahrgang 21, Nr. 11, 11.2023, S. 1315-1318.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Kurzpublikation › Forschung › Begutachtung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Therapy of necrobiotic xanthogranuloma - case series and review of the literature
AU - Hansen, Inga
AU - Ghandili, Susanne
AU - Abeck, Finn
AU - Booken, Nina
AU - Schneider, Stefan W
N1 - © 2023 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.
PY - 2023/11
Y1 - 2023/11
N2 - Necrobiotic xanthogranuloma is a rare disease that is part of the non-Langerhans cell histiocytoses. It is characterized by yellowish skin lesions, which are typically periorbitally localized. Extracutaneous manifestations of all organs are possible and can cause potentially life-threatening complications. The disease also belongs to the facultative paraneoplasias and is often associated with paraproteinemia. These aspects should be considered regarding further diagnostics. Due to the rarity of the disease, there are no standardized guidelines for therapy so far. The combination of prednisolone and chlorambucil as well as intravenous immunoglobulins seem to be effective therapeutic options. We present four cases from our clinic as well as the current results of the literature in this mini-review and would like to highlight the therapeutic challenge as well as the need for the development of guidelines.
AB - Necrobiotic xanthogranuloma is a rare disease that is part of the non-Langerhans cell histiocytoses. It is characterized by yellowish skin lesions, which are typically periorbitally localized. Extracutaneous manifestations of all organs are possible and can cause potentially life-threatening complications. The disease also belongs to the facultative paraneoplasias and is often associated with paraproteinemia. These aspects should be considered regarding further diagnostics. Due to the rarity of the disease, there are no standardized guidelines for therapy so far. The combination of prednisolone and chlorambucil as well as intravenous immunoglobulins seem to be effective therapeutic options. We present four cases from our clinic as well as the current results of the literature in this mini-review and would like to highlight the therapeutic challenge as well as the need for the development of guidelines.
U2 - 10.1111/ddg.15195
DO - 10.1111/ddg.15195
M3 - Short publication
C2 - 37811744
VL - 21
SP - 1315
EP - 1318
JO - J DTSCH DERMATOL GES
JF - J DTSCH DERMATOL GES
SN - 1610-0379
IS - 11
ER -
